Cumberland Pharmaceuticals Inc (CPIX) stock

CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value

$6.12+0.82 (+15.47%)

Close on Nov 11, 2026Market cap $91.70MP/E –Yield –

Cumberland Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cumberland Pharmaceuticals's EV/EBITDA was 37.6× on Apr 30, 2026, against 82.2× a year earlier. Over the last 5 years it ranged from 1.2× to 110.9×, with a median of 14.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Apr 30, 2026	37.6×	+13.7
2025	Jul 31, 2025	23.9×	+1.5
2023	Oct 31, 2023	22.4×	−70.2
2021	Oct 29, 2021	92.6×	+10.4
2017	Jul 31, 2017	82.2×	+56.0
2016	Dec 30, 2016	26.2×	+14.0
2015	Dec 31, 2015	12.1×	−21.6
2014	Dec 31, 2014	33.7×	+18.6
2013	Dec 31, 2013	15.1×	+11.5
2012	Dec 31, 2012	3.6×	+0.3
2011	Dec 30, 2011	3.3×	−1.3
2010	Dec 31, 2010	4.6×	–

Where these numbers come from

Parsed from the XBRL in Cumberland Pharmaceuticals's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing